SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-19-010176
Filing Date
2019-06-06
Accepted
2019-06-06 12:35:44
Documents
2
Group Members
FENGYUN JIANGPEIXIN XU

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D sc13d0619a1bison_xynomic.htm SC 13D/A 75258
2 JOINT FILING AGREEMENT, DATED MAY [XX], 2019 sc13d0619a1ex99-1bison_xyno.htm EX-99.1 4273
  Complete submission text file 0001213900-19-010176.txt   81481
Mailing Address 609-610, 21ST CENTURY TOWER 40 LIANGMAQIAO RD, CHAOYANG DISTRICT BEIJING F4 100016
Business Address 609-610, 21ST CENTURY TOWER 40 LIANGMAQIAO RD, CHAOYANG DISTRICT BEIJING F4 100016 8618610840084
Bison Capital Holding Co Ltd (Filed by) CIK: 0001593415 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 609-610 21ST CENTURY TOWER 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT BEIJING F4 100016
Business Address 609-610 21ST CENTURY TOWER 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT BEIJING F4 100016 9493506999
XYNOMIC PHARMACEUTICALS HOLDINGS, INC. (Subject) CIK: 0001697805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90028 | Film No.: 19881962
SIC: 2834 Pharmaceutical Preparations